RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol

Vaccine

Volumn 25, Issue 42, 2007, Pages 7459-7469

  Smallshaw, Joan E ^a   Richardson, James A ^a   Vitetta, Ellen S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bioterrorism; Ricin; RiVax; Vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; RECOMBINANT VACCINE; RICIN A; RIVAX; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; HISTOPATHOLOGY; IMMUNOGENICITY; LD 50; LUNG FUNCTION TEST; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; AEROSOLS; ANIMALS; BIOTERRORISM; GENES, PLANT; HUMANS; INJECTIONS, INTRAMUSCULAR; INTESTINES; LETHAL DOSE 50; LUNG; MICE; MUTATION; PLANTS, TOXIC; RICIN; RICINUS; VACCINES; VACCINES, SYNTHETIC;

EID: 34748918488     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.018     Document Type: Article

References (32)

1. Doan L.G. Ricin: mechanism of toxicity, clinical manifestations, and vaccine development. A review. J Toxicol Clin Toxicol 42 2 (2004) 201-208
2. Audi J., Belson M., Patel M., Schier J., and Osterloh J. Ricin poisoning: a comprehensive review. JAMA 294 18 (2005) 2342-2351
3. Franz D.R., and Jaax N.K. Ricin toxin. In: Zajtchuk R., and Bellamy R.F. (Eds). Textbook of military medicine (1997), Office of the Surgeon General at TMM Publications, Borden Inst., Walter Reed Army Medical Center, Washington, DC 631-642
4. Hewetson J.F., Rivera V.R., Creasia D.A., Lemley P.V., Rippy M.K., and Poli M.A. Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibody. Vaccine 11 7 (1993) 743-746
5. Lemley P.V., Amanatides P., and Wright D.C. Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo. Hybridoma 13 5 (1994) 417-421
6. Griffiths G.D., Bailey S.C., Hambrook J.L., and Keyte M.P. Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. Vaccine 16 5 (1998) 530-535
7. Poli M.A., Rivera V.R., Pitt M.L., and Vogel P. Aerosolized specific antibody protects mice from lung injury associated with aerosolized ricin exposure. Toxicon 34 9 (1996) 1037-1044
8. Foxwell B.M., Detre S.I., Donovan T.A., and Thorpe P.E. The use of anti-ricin antibodies to protect mice intoxicated with ricin. Toxicology 34 1 (1985) 79-88
9. Smallshaw J.E., Firan A., Fulmer J.R., Ruback S.L., Ghetie V., and Vitetta E.S. A novel recombinant vaccine which protects mice against ricin intoxication. Vaccine 20 27-28 (2002) 3422-3427
10. Smallshaw J.E., Richardson J.A., Pincus S., Schindler J., and Vitetta E.S. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Vaccine 23 39 (2005) 4775-4784
11. Vitetta E.S., Smallshaw J.E., Coleman E., Jafri H., Foster C., Munford R., et al. A pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc Natl Acad Sci USA 103 7 (2006) 2268-2273
12. Holmgren J., Brantzaeg P., Capron A., Francotte M., Kilian M., Kraehenbuhl J.P., et al. Concerted efforts in the field of mucosal immunology; Reports of the Expert Panel VI. European Commission Cost/STD Initiative. Vaccine 14 (1996) 644-664
13. O'Hare M., Brown A.N., Hussain K., Gebhardt A., Watson G., Roberts L.M., et al. Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence. FEBS Lett 273 (1990) 200-204
14. Simpson J.C., Lord J.M., and Roberts L.M. Point mutations in the hydrophobic C-terminal region of ricin A chain indicate that Pro250 plays a key role in membrane translocation. Eur J Biochem 232 (1995) 458-463
15. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
16. Ghetie V., and Vitetta E.S. Chemical construction of immunotoxins. Mol Biotechnol 18 3 (2001) 251-268
17. Depledge M.H. Respiration and lung function in the mouse, Mus musculus (with a note on mass exponents and respiratory variables). Resp Physiol 60 1 (1985) 83-94
18. Rios A.M., Mejias A., Chavez-Bueno S., Fonseca-Aten M., Katz K., Hatfield J., et al. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Antimicrob Agents Chemother 48 8 (2004) 2897-2904
19. Balint G.A. Ricin: the toxic protein of castor oil seeds. Toxicology 2 1 (1974) 77-102
20. Lippmann M., and Schlesinger R.B. Interspecies comparisons of particle deposition and mucociliary clearance in tracheobronchial airways. J Toxicol Environ Health 13 2-3 (1984) 441-469
21. Pincus S.H., Eng L., Cooke C.L., and Maddaloni M. Identification of hypoglycemia in mice as a surrogate marker of ricin toxicosis. Comp Med 52 6 (2002) 530-533
22. Covell D.G., Barbet J., Holton O.D., Black C.D., Parker R.J., and Weinstein J.N. Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice. Cancer Res 46 (1986) 3969-3978
23. Twigg III H.L. Humoral immune defense (antibodies): recent advances. Proc Am Thorac Soc 2 5 (2005) 417-421
24. Sekine I., Kawase Y., Nishimori I., Mitarai M., Harada H., Ishiguro M., et al. Pathological study on mucosal changes in small intestine of rat by oral administration of ricin. I: Microscopical observation. Acta Pathol Jpn 36 8 (1986) 1205-1212
25. Ishiguro M., Tanabe S., Matori Y., and Sakakibara R. Biochemical studies on oral toxicity of ricin. IV: A fate of orally administered ricin in rats. J Pharmacobio-Dyn 15 4 (1992) 147-156
26. Yoder J.M., Aslam R.U., and Mantis N.J. Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication infect. Immunity 75 4 (2007) 1745-1750
27. Wong J., Korcheva V., Jacoby D.B., and Magun B. Intrapulmonary delivery of ricin at high dosage triggers a systemic inflammatory response and glomerular damage. Am J Pathol 170 5 (2007) 1497-1510
28. Griffiths G.D., Lindsay C.D., Allenby A.C., Bailey S.C., Scawin J.W., Rice P., et al. Protection against inhalation toxicity of ricin and abrin by immunisation. Hum Exp Toxicol 14 2 (1995) 155-164
29. Yan C., Rill W.L., Malli R., Hewetson J., Naseem H., Tammariello R., et al. Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres. Vaccine 14 11 (1996) 1031-1038
30. Kende M., Yan C., Hewetson J., Frick M.A., Rill W.L., and Tammariello R. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge. Vaccine 20 11-12 (2002) 1681-1691
31. Marsden C.J., Knight S., Smith D.C., Day P.J., Roberts L.M., Phillips G.J., et al. Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine. Vaccine 22 21-22 (2004) 2800-2805
32. Olson M.A., Carra J.H., Roxas-Duncan V., Wannemacher R.W., Smith L.A., and Millard C.B. Finding a new vaccine in the ricin protein fold. Protein Eng Des Sel 17 4 (2004) 391-397